Seak Therapeutics
SEAK Therapeutics LLC, founded in November 2018 by Dr. Wei Li, is a Memphis-based startup dedicated to the discovery and development of innovative targeted small-molecule drugs aimed at improving the health of pediatric cancer patients and individuals suffering from neurological diseases. The company's mission focuses on creating therapeutic agents that specifically target over-activated expressions related to these conditions.
In its early stages of development, SEAK Therapeutics has garnered support from various funding sources, including the NIH SBIR STTR grant programs and the LaunchTN matching grant programs. The company is also open to angel investments and other forms of support to further its research and product development efforts.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.